Pulmonx Corporation
Pulmonx Corporation (LUNG) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
lung · pe ratio · data through Dec 31, 2025
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Pulmonx Corporation (LUNG) measures how much investors pay for each dollar of the company's trailing earnings. LUNG's current PE ratio of N/A is calculated by dividing its stock price of $1.50 by its TTM earnings per share of -$1.27.
Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31
PE Ratio History
2018 – 2025 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
PE Ratio vs Peers
Medical - Devices · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Pulmonx CorporationYou LUNG | $63M | N/A | — | -$1.27 |
 Acrivon Therapeutics, Inc. Common Stock ACRV | $46M | N/A | — | -$2.02 |
 Assertio Holdings, Inc. ASRT | $151M | N/A | — | -$4.74 |
 Edap Tms S.a. EDAP | $178M | N/A | — | -$0.78 |
 Hyperfine, Inc. HYPR | $121M | N/A | — | -$0.38 |
 Immunic, Inc. IMUX | $127M | N/A | — | -$6.24 |
 PMV Pharmaceuticals, Inc. PMVP | $59M | N/A | — | -$1.48 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2025-12-31Latest FY2025 | — | $-1.33 | — | |
2024-12-31 FY2024 | — | $-1.44 | — | |
2023-12-31 FY2023 | — | $-1.60 | — | |
2022-12-31 FY2022 | — | $-1.59 | — | |
2021-12-31 FY2021 | — | $-1.35 | — | |
2020-12-31 FY2020 | — | $-0.90 | — | |
2019-12-31 FY2019 | — | $-0.58 | — | |
2018-12-31 FY2018 | — | $-0.89 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Pulmonx Corporation (LUNG) measures how much investors pay for each dollar of the company's trailing earnings. LUNG's current PE ratio of N/A is calculated by dividing its stock price of $1.50 by its TTM earnings per share of -$1.27.
Frequently asked questions
LUNG pe ratio · 6 questionsLUNG's current PE ratio is N/A as of 2026-06-09, based on a stock price of $1.50 and TTM EPS of -$1.27. Data sourced from Financial Modeling Prep via LUNG's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Pulmonx Corporation SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09